Tag: Paroxysmal nocturnal hemoglobinuria

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Paroxysmal nocturnal hemoglobinuria

Morgan Stanley Joins Other Big Banks in Bond Sales

Added to Collection on: 2021-04-20 21:26:30

Tags for this article:

Computing
Computer networking
Finance
TipRanks
Food and Drug Administration
DigitalOcean
Goldman Sachs
Prescription Drug User Fee Act
Paroxysmal nocturnal hemoglobinuria
Volatility

Click the tags to see associated articles and topics

View Article Details
RAM Group Germany Awarded XPRIZE for Rapid COVID Testing Using Sensors Instead of PCR ...

Added to Collection on: 2021-04-20 18:45:00

Tags for this article:

Computing
Computer networking
Finance
TipRanks
Food and Drug Administration
DigitalOcean
Goldman Sachs
Prescription Drug User Fee Act
Paroxysmal nocturnal hemoglobinuria
Volatility

Click the tags to see associated articles and topics

View Article Details
Novogratz on crypto ETFs: There's no doubt Canada is one step ahead of the US

Added to Collection on: 2021-04-21 20:15:00

Tags for this article:

Computing
Computer networking
Finance
TipRanks
Food and Drug Administration
DigitalOcean
Goldman Sachs
Prescription Drug User Fee Act
Paroxysmal nocturnal hemoglobinuria
Volatility

Click the tags to see associated articles and topics

View Article Details
FDA Clears Ravulizumab for Neuromyelitis Optica Spectrum Disorder - Medscape

Added to Collection on: 2024-03-25 20:42:21

Tags for this article:

Rare diseases
Orphan drugs
Monoclonal antibodies
Blood disorders
Acquired hemolytic anemia
Neuromyelitis optica spectrum disorder
Atypical hemolytic uremic syndrome
Eculizumab
Ravulizumab
Hemolytic–uremic syndrome
Multiple sclerosis
Paroxysmal nocturnal hemoglobinuria

Click the tags to see associated articles and topics

View Article Details
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies

Added to Collection on: 2024-04-18 20:19:56

Tags for this article:

Orphan drugs
Monoclonal antibodies
Immunosuppressants
Acquired hemolytic anemia
Health economics
Paroxysmal nocturnal hemoglobinuria
Pegcetacoplan
Eculizumab
Ravulizumab
PNH
Quality-adjusted life year
Cost–utility analysis

Click the tags to see associated articles and topics

View Article Details
US FDA approves Roche's drug for a chronic blood disorder - The Indian Express

Added to Collection on: 2024-06-21 22:55:23

Tags for this article:

Monoclonal antibodies
Blood disorders
Orphan drugs
Rare diseases
Acquired hemolytic anemia
Paroxysmal nocturnal hemoglobinuria
Eculizumab
Atypical hemolytic uremic syndrome
Crovalimab
Ravulizumab
Hemolytic–uremic syndrome
Hemolysis
Roche Pharma
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Roche's PIASKY Approval for Paroxysmal Nocturnal Hemoglobinuria Treatment Will Give ...

Added to Collection on: 2024-09-02 21:31:58

Tags for this article:

Orphan drugs
Immunosuppressants
Monoclonal antibodies
Hematology
Pegcetacoplan
Crovalimab
Eculizumab
Iptacopan
Alexion Pharmaceuticals
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
Danicopan
United States
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Novel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) - GlobeNewswire

Added to Collection on: 2024-12-08 00:03:59

Tags for this article:

Orphan drugs
Monoclonal antibodies
Immunosuppressants
Hematology
Rare diseases
Ravulizumab
Paroxysmal nocturnal hemoglobinuria
Lactate dehydrogenase
Hemolysis
Anemia
Eculizumab

Click the tags to see associated articles and topics

View Article Details
Long-Term Data Support Use of Eculizumab Biosimilar as Soliris Alternative in PNH

Added to Collection on: 2025-01-28 17:14:20

Tags for this article:

Acquired hemolytic anemia
Rare diseases
Blood disorders
Immunosuppressants
Orphan drugs
Paroxysmal nocturnal hemoglobinuria
Atypical hemolytic uremic syndrome
Eculizumab
Hemolysis
Hemolytic–uremic syndrome
Biosimilar
Hemolytic anemia

Click the tags to see associated articles and topics

View Article Details
Health Canada approves Novartis' Fabhalta for PNH with haemolytic anaemia

Added to Collection on: 2025-02-14 17:39:28

Tags for this article:

Hematology
Immunosuppressants
Orphan drugs
Indoles
Iptacopan
Paroxysmal nocturnal hemoglobinuria
PNH
Novartis
Hemolytic anemia
Hemolysis
Crovalimab
Paroxysmal attack

Click the tags to see associated articles and topics

View Article Details
Book a Demo